AQUINOX PHARMACEUTICALS CANADA
Aquinox Pharmaceuticals Canada is a research and development-focused company that develops pharmaceutical products.
AQUINOX PHARMACEUTICALS CANADA
Industry:
Life Science Pharmaceutical Product Research
Address:
Vancouver, British Columbia, Canada
Country:
Canada
Status:
Active
More informations about "Aquinox Pharmaceuticals Canada" on Search Engine
Aquinox Pharmaceuticals - Pharmstd Ventures
IPO in March, 2014. Aquinox is a clinical-stage pharmaceutical company developing targeted small molecule therapeutics for the treatment of cancer and inflammatory disease.Its lead product, AQX-1125, is aselective allosteric activator of SHIP1, a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K …See details»
Interview: David Main – CEO and President, Aquinox …
26.01.2018. David Main, CEO and president of Aquinox Pharmaceuticals Inc., introduces the company he founded in 2006, which now is in the late stages of development of a drug targeting the SHIP1 enzyme, with a focus on treating interstitial cystitis/bladder pain …See details»
Taro Pharmaceuticals acquires Aquinox …
Jul 29, 2020 Acquired Organization: Aquinox Pharmaceuticals Canada Aquinox Pharmaceuticals Canada is a research and development-focused company that develops pharmaceutical products. Acquiring Organization: Taro Pharmaceuticals Taro Pharmaceuticals is a research-based pharmaceutical company that develops over-the …See details»
Aquinox Pharmaceuticals (Canada) Company Profile: …
Description. Provider of research and development based in British Columbia, Canada. The company offers research of pharmaceutical products for purposes of their commercialization. Contact Information. Ownership Status. Acquired/Merged. Financing Status. Corporate Backed or Acquired. Primary Industry. Pharmaceuticals. Acquirer.See details»
Generalist, Human Resources | Aqx Canadian Pharmacy
Generalist, Human Resources. Aquinox is a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology.See details»
Sun Pharma-owned subsidiary to acquire Canada's …
Jul 29, 2020 Sun Pharmaceutical Industries on Wednesday said that a wholly-owned subsidiary of Taro Pharmaceutical Industries Ltd will acquire Aquinox Pharmaceuticals (Canada) Inc for $8.2 million. Taro Pharmaceutical is a US-based subsidiary of Sun Pharmaceutical.See details»
Aquinox Pharmaceuticals and Neoleukin Therapeutics announce …
Aug 6, 2019 Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) is a pharmaceutical company discovering and developing novel therapeutics for conditions marked by inflammation, inflammatory pain, and blood cancers. About Neoleukin Therapeutics, Inc.See details»
Aquinox Pharmaceuticals, Inc - Prairie Bio Sciences
GLOBE 2020. Training. Links & Supporters. Contact. Aquinox Pharmaceuticals, Inc. (Aquinox, NASDAQ:AQXP) is a clinical-stage pharmaceutical company developing novel drug candidates to treat …See details»
Sun Pharma to acquire Canada-based Aquinox …
Jul 29, 2020 Sun Pharma to acquire Canada-based Aquinox Pharmaceuticals for 8.2 mn. The subsidiary of Taro Pharmaceutical will acquire 100 per cent stake in the company. SNS | New Delhi | July 29,...See details»
Aquinox Pharmaceuticals - Products, Competitors, Financials, …
It focuses on the development of therapeutics that assists in making a clinically meaningful difference. The company was founded in 2006 and is based in Vancouver, Canada. In July 2020, Aquinox Pharmaceuticals was acquired by Sun Pharma. The terms of the transaction were not disclosed.See details»
Aquinox Pharmaceuticals Inc. Company Profile | Vancouver, BC, …
Find company research, competitor information, contact details & financial data for Aquinox Pharmaceuticals Inc. of Vancouver, BC. Get the latest business insights from Dun & Bradstreet.See details»
Scientist, Clinical Research | Aqx Canadian Pharmacy
About Aquinox: Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology.See details»
Aquinox Pharmaceuticals (Canada), Inc.: Drug pipelines, Patents ...
Jul 2, 2023 Explore Aquinox Pharmaceuticals (Canada), Inc. with its drug pipeline, therapeutic area, technology platform, 7 clinical trials, and 1 literature, Drug:Rosiptor.See details»
Sun Pharma-Aquinox Pharmaceuticals News Sun Pharma …
Jul 29, 2020 Sun Pharmaceutical Industries on Wednesday announced the acquisition of Canada-based Aquinox Pharmaceuticals (Canada) Inc for $8.2 million through its wholly-owned subsidiary Taro Pharmaceutical Industries.See details»
Aquinox Pharmaceuticals commences Phase 2 clinical trial of …
May 13, 2023 Aquinox Pharmaceuticals Inc. is a clinical stage pharmaceutical company discovering and developing novel, small molecule therapeutics targeting SH2-containing inositol-5’-phosphatase 1 (“ SHIP1 “) for the treatment of inflammatory disease and cancer.See details»
Aquinox Pharmaceuticals (Canada) Inc. - Company & Director …
Dec 26, 2003 Aquinox Pharmaceuticals (Canada) Inc. is a Non-distributing corporation with 50 or fewer shareholders company type , located at Suite 2400, 745 Thurlow Street Vancouver BC V6E 0C5 Canada. It was incoporated on 26-Dec-2003, the company's business number is 867253601RC0001 and corporation number is 6175813.See details»
Aquinox Pharmaceuticals Completes US $18 million Series C …
Apr 3, 2013 VANCOUVER, BRITISH COLUMBIA-- (Marketwired - Apr 3, 2013) - Aquinox Pharmaceuticals Inc., a private, venture-backed, pharmaceutical company developing novel and targeted small molecule...See details»
Aquinox Pharmaceuticals and Neoleukin Therapeutics announce
Aug 6, 2019 VANCOUVER, British Columbia and SEATTLE, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“ Aquinox ”) (NASDAQ: AQXP) and Neoleukin Therapeutics, Inc. (“Neoleukin”), a...See details»
What Kind Of Shareholder Appears On The Aquinox …
Apr 26, 2019 The big shareholder groups in Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) have power over the company. Large companies usually have institutions as shareholders, and we usually see insiders owning ...See details»
Aquinox Pharmaceuticals and Neoleukin Therapeutics Announce …
Aug 7, 2019 VANCOUVER, British Columbia and SEATTLE (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP) and Neoleukin Therapeutics, Inc. (“Neoleukin”), a privately held biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced that the …See details»